These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2006-003607-40 A CONTROLLED, RANDOMISED, DOUBLE-BLIND, MULTICENTER STUDY, COMPARING METHOTREXATE VS PLACEBO IN CORTICOSTEROID-DEPENDENT ULCERATIVE COLITIS 2014-10-17 bad-data
Listed as ongoing, but also has a completion date 2006-005299-42 A randomized, multicenter open label study comparing cyclosporine with infliximab in steroid-refractory severe attacks of ulcerative colitis (CYSIF Study) 2013-08-28 bad-data
Ongoing 2009-011316-38 ESSAI MULTICENTRIQUE RANDOMISE CONTROLE, AVEC DEUX GROUPES PARALLELES, EN DOUBLE AVEUGLE, COMPARANT LE FERRISAT®AU PLACEBO DANS L’ANEMIE ASSOCIEE AUX MICI AU COURS DU TRAITEMENT PAR ANTI-TNF ALPHA not-yet-due
Listed as ongoing, but also has a completion date 2011-003038-14 A RANDOMIZED CONTROLLED TRIAL INVESTIGATING TAILORED TREATMENT WITH INFLIXIMAB FOR ACTIVE LUMINAL CROHN'S DISEASE Een gerandomiseerd, gecontroleerd onderzoek naar een passende behandeling met Infli... 2015-07-28 bad-data
Listed as ongoing, but also has a completion date 2013-003199-11 Changing the coUrse of cRohn's disease with an Early use of adalimumab: The CURE study. 2024-06-04 bad-data
Ongoing 2014-002311-41 A proSpective randomized controlled trial comParing infliximAb-antimetabolites combination therapy to anti-metabolites monotheRapy and infliximab monothErapy in Crohn’s disease patients in sustained s... not-yet-due
Not reported 2016-000152-96 Intensive Treatment to Reach the target with Golimumab in ulcErative coliTis – In-TARGET Traitement intensif par golimumab pour atteindre la cible thérapeutique dans la rectocolite hémorragique (RC... 2022-09-05 due-trials
Other 2018-003490-10 An open-label randomized trial COmparing staNdard of care versus Treat to target with telemonitoRing and patient education in patients with ulcerative cOlitis initiating adalimumab : The CONTROL trial not-yet-due
Other 2019-001337-13 USTekinumab in fistulising Perianal Crohn’s Disease: The USTAP CD study not-yet-due
Other 2021-002369-17 Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial, the POMEROL trial. not-yet-due